News
Insightin Health Creates Comprehensive Solution Aimed at Cutting Healthcare Costs and Creating a Healthier Medicare Advantage Population
May 22, 2019
15+ years of analytics and digital marketing experience to include customer acquisition, retention, and win-back. Proven solutions for Kaiser Permanente, La Quinta, Dickies, Johns Hopkins Healthcare, Magellan, Highmark, Masterbrand, Target, and other prominent industry leading brands. Successfully architected several multi-million dollar campaign automation to improve ROI. Gartner CRM Excellence Award Winning Member Engagement Campaign. Multi year customer engagement automation resulted in $300M+ gained revenue for a Healthcare Client.
Michael brings 20+ years of experience in consulting, technology implementation, and business analysis for various direct to consumer industries, with a concentration in healthcare. Michael’s deep insight in Medicare Advantage market place provides the Insightin team with a strategic view from the health plan’s prospective. Michael provides strategic consulting and technology implementation strategy for our clients.
10+ years of hands on software development. Architected system design for multiple industry leading brands- Target, Highmark, Johns Hopkins, Kaiser Permanente, University of Pennsylvania. 5+ years experience of managing 20+ member software development team. Lead architect and responsible for all development efforts for Insightin | Health Cloud platform.
Marcia brings 15+ years of experience working directly with clients on solving problems around technology training and instructional designs. Marcia had worked on multiple patient engagement platforms to deliver learning courses for physicians and nurses. As, the compliance officer, she oversees all aspect of PHI and HIPAA compliance for our technology solutions.
Founding Principal at Blu Venture Investors. Launched and grew In Vitro Technologies, Inc. for 15 years as President & CEO. Led successful sale of Company for $30M in 2006. Currently Board Director or Advisor to Encore Path, Inc., PA & Associates, Inc, Evergreen Advisors LLC, PathSensors, Inc., and The Biotechnical Institute of Maryland. Chair of the Greater Baltimore Technology Council’s Biotech Roundtable. Ph.D. in Toxicology, 5 patents. Proven track record of growing a successful B2B technology company from inception to sale, focusing on innovation, execution, and creation of a valuable brand. Investor in several Companies including: Pathsensors, Oculis Labs, Straighterline, Encore Path, LiveLook and Kanasao.
Charles Boorady has over 25 years of professional experience with healthcare investment and information technology.
Mr. Boorady’s career includes over 20 years as a leading healthcare equity analyst with major investment banks including Credit Suisse, Goldman Sachs, and Citi. As an equity analyst, he was: ranked #1 by Institutional Investor Magazine for his coverage of Managed Care, for which he ranked top 3 in the country for over a decade; named among the “Dazzling Dozen” by Forbes Magazine, and; often quoted in national and trade press for his insights on healthcare industry trends. In an earlier stage of his career, Mr. Boorady was a technology consultant for Accenture, a global consulting firm. He is a Founding Advisory Board member of The Oliver Wyman Health Innovation Center, convening leaders to identify business solutions to improve healthcare outcomes. Mr. Boorady has an MBA in Analytic Finance and Statistics from The University of Chicago and a BS in Engineering from Cornell University
